Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Immuron (IMRN) Debt to Equity (2016 - 2022)

Immuron's quarterly Debt to Equity came in at $15.06 in Q2 2022, up 40.07% year-on-year from $10.76 in Q2 2021, and up 40.07% quarter-over-quarter from $10.76 in Q2 2021.

Immuron has reported Debt to Equity for 6 years, with the latest figure at $15.06 in Q2 2022.

  • For the quarter ending Q2 2022, Debt to Equity rose 40.07% year-over-year to $15.06; the trailing twelve-month figure through Jun 2022 stood at $15.06 (up 40.07% YoY), and the FY2020 full-year result was $0.01, up 298.38% from the prior year.
  • Debt to Equity for Q2 2022 stood at $15.06, up from $10.76 in the prior quarter.
  • The five-year high for Debt to Equity was $15.06 in Q2 2022, with the low at $0.0 in Q2 2019.
  • Average Debt to Equity over 4 years is $6.46, with a median of $5.38 recorded in 2020.
  • Year-over-year, Debt to Equity surged 145218.46% in 2021 and surged 40.07% in 2022.
  • Tracing IMRN's Debt to Equity over 4 years: stood at $0.0 in 2019, then jumped by 298.38% to $0.01 in 2020, then jumped by 145218.46% to $10.76 in 2021, then surged by 40.07% to $15.06 in 2022.
  • The last three Debt to Equity figures came in at $15.06 (Q2 2022), $10.76 (Q2 2021), and $0.01 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 15.06
Jun 30, 2021 10.76
Jun 30, 2020 0.01
Jun 30, 2019 0.00
Dec 31, 2017 0.05
Jun 30, 2017 0.02
Dec 31, 2016 0.23